Agrow is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US weather dampens Amvac's Q2 expectations

Delayed planting due to wet conditions in the US has had an adverse effect on US agrochemical company American Vanguard's expected second-quarter results. While sales are expected to exceed those recorded in the second quarter of 2012, they will be lower than forecast. The impact on earnings is uncertain at this stage but revenues and earnings are likely to be below those expected by analysts, the company points out. Sales of the post-emergence maize herbicide, Impact (BASF's topramezone), are expected to be "considerably higher" than in the same period last year, but below forecasts. Some sales are likely to shift from the second quarter to the third quarter. The wet conditions have reduced cotton plantings, with some analysts pointing to a 25% drop, Amvac notes. Sales of the company's cotton insecticide, Bidrin (dicrotophos), and its cotton defoliant, Folex (tribufos), are therefore expected to be "well below" forecasted levels. The company's sales grew by over 39% to $121.5 million in the first quarter of this year (Agrow No 664, p 7).

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AG012568

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel